Alpha Healthcare Acquisition Corp.

Launch Peripheral Arterial Disease product in the US

Deadline passed; outcome being checked

Announced: 17 Feb 2021
Due: 31 Dec 2025
Status: Checking

Deadline
Met
Late
Not met
Today

What the company said

“Peripheral Arterial Disease • Vein grafts not always available; PTFE fails early • HAVs have 78% function at 2 years • 100,000+ PAD operations per year in US Expected US Launch: 2025”

SourceAlpha Healthcare Acquisition Corp. Form 8-K press release, 2021-02-17
FilingSEC filing index
Deadline as stated2025
Deadline used31 Dec 2025, the last day of the stated period
TypeProduct
Permanent referenceKI-C-2021-HUMA-024028
Cite as https://keptindex.org/c/KI-C-2021-HUMA-024028/ — this address never changes.

What we found

The deadline has passed. We check for public evidence starting 30 days after the deadline, and repeat the check if nothing clear turns up.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Commercial launch
Indicative materiality: Medium rules
Action: Launch
Deliverable: Peripheral Arterial Disease product
Where: US
Language: Expected (“expects”, “plans”)
In the company’s control: Medium
Specificity: High
Depends on: Regulatory

Tell me what happens

This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.

Alert me when this resolves

How this entry was checked

Commitment recordedThe company's words were matched word for word against the filing.
OutcomeNot yet assessed. Nothing is judged before the deadline.

Are you Alpha Healthcare Acquisition Corp.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-HUMA-024028 · Corrections policy